相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemoresistance in Ovarian Cancer: Prospects for New Drugs
Shivani Tendulkar et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis
Nuo Li et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Targeting EHMT2/G9a for cancer therapy: Progress and perspective
Suraya Jan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
The rediscovery of platinum-based cancer therapy
Sven Rottenberg et al.
NATURE REVIEWS CANCER (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells
Haiyu Zhang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1
Cheng Cheng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
Maria E. Reyes et al.
FRONTIERS IN IMMUNOLOGY (2020)
Clinical Significance of ZNF711 in Human Breast Cancer
Xiaoyan Li et al.
ONCOTARGETS AND THERAPY (2020)
The roles of DNA, RNA and histone methylation in ageing and cancer
Ewa M. Michalak et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake
Xiaoxue Lv et al.
MOLECULAR CARCINOGENESIS (2019)
FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer
Yun-Cheol Chae et al.
NUCLEIC ACIDS RESEARCH (2019)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream from transcription start sites at the majority of CpG island promoters
Suhn Kyong Rhie et al.
GENOME RESEARCH (2018)
The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer
Sudha S. Savant et al.
CANCERS (2018)
Mutations in two large pedigrees highlight the role of ZNF711 in X-linked intellectual disability
Ilse M. van der Werf et al.
GENE (2017)
Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases
Kanishk Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
In Situ Capture of Chromatin Interactions by Biotinylated dCas9
Xin Liu et al.
CELL (2017)
Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer
Thai Q. Tran et al.
CLINICAL CANCER RESEARCH (2017)
BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine
Mariana Lazarini et al.
HAEMATOLOGICA (2016)
BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine
Mariana Lazarini et al.
HAEMATOLOGICA (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Zinc finger proteins in cancer progression
Jayu Jen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
Histone methylation modifiers in cellular signaling pathways
Hunain Alam et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Ovarian cancer standard of care: are there real alternatives?
Chiara Della Pepa et al.
CHINESE JOURNAL OF CANCER (2015)
miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway
Liang Shi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer
Pierre-Emmanuel Colombo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease
Natalie K. Y. Wee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Advanced ovarian cancer: what should be the standard of care?
Barbara A. Goff
JOURNAL OF GYNECOLOGIC ONCOLOGY (2013)
EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
Chunxi Wang et al.
CANCER RESEARCH (2012)
Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)
Xiubo Du et al.
METALLOMICS (2012)
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Seiko Ishida et al.
CANCER CELL (2010)
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Daniel P. Silver et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Functional Link between the Histone Demethylase PHF8 and the Transcription Factor ZNF711 in X-Linked Mental Retardation
Daniela Kleine-Kohlbrecher et al.
MOLECULAR CELL (2010)
The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
Christopher A. Larson et al.
MOLECULAR PHARMACOLOGY (2009)
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation
Patrick S. Tarpey et al.
NATURE GENETICS (2009)
Linking DNA methylation and histone modification: patterns and paradigms
Howard Cedar et al.
NATURE REVIEWS GENETICS (2009)
Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis
Yuki Okada et al.
NATURE (2007)
The roles of copper transporters in cisplatin resistance
Macus Tien Kuo et al.
CANCER AND METASTASIS REVIEWS (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin
Alison K. Holzer et al.
MOLECULAR PHARMACOLOGY (2006)
G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis
N Feldman et al.
NATURE CELL BIOLOGY (2006)
Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer
T Le et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs
R Safaei et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells
G Samimi et al.
CLINICAL CANCER RESEARCH (2004)
Histone modification: the 'next wave' in cancer therapeutics
D Chung
TRENDS IN MOLECULAR MEDICINE (2002)
分享论文
